Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125451052 | 12545105 | 2 | F | 2014 | 20160728 | 20160711 | 20160803 | EXP | FR-PFIZER INC-2016331333 | PFIZER | 72.00 | YR | F | Y | 0.00000 | 20160803 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125451052 | 12545105 | 1 | PS | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, 2X/DAY | 18276 | .5 | MG | TABLET | BID | ||||||
| 125451052 | 12545105 | 2 | SS | ATIVAN | LORAZEPAM | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 125451052 | 12545105 | 3 | SS | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 125451052 | 12545105 | 4 | SS | MICARDIS | TELMISARTAN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 125451052 | 12545105 | 5 | C | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, 1X/DAY | 0 | 1.2 | MG | QD | |||||||
| 125451052 | 12545105 | 6 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | 25 UG, 1X/DAY | 0 | 25 | UG | TABLET | QD | ||||||
| 125451052 | 12545105 | 7 | C | PREVISCAN /00789001/ | FLUINDIONE | 1 | Oral | 0.75 MG, 1X/DAY | 0 | .75 | MG | QD | |||||||
| 125451052 | 12545105 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125451052 | 12545105 | 1 | Anxiety |
| 125451052 | 12545105 | 2 | Depression |
| 125451052 | 12545105 | 3 | Insomnia |
| 125451052 | 12545105 | 4 | Hypertension |
| 125451052 | 12545105 | 5 | Type 2 diabetes mellitus |
| 125451052 | 12545105 | 6 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125451052 | 12545105 | HO |
| 125451052 | 12545105 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125451052 | 12545105 | Agitation | |
| 125451052 | 12545105 | Blood creatine phosphokinase increased | |
| 125451052 | 12545105 | C-reactive protein increased | |
| 125451052 | 12545105 | Confusional state | |
| 125451052 | 12545105 | Crepitations | |
| 125451052 | 12545105 | Dehydration | |
| 125451052 | 12545105 | Dyspnoea | |
| 125451052 | 12545105 | Fall | |
| 125451052 | 12545105 | Hyperglycaemia | |
| 125451052 | 12545105 | Hypokalaemia | |
| 125451052 | 12545105 | Inflammation | |
| 125451052 | 12545105 | Myoglobin blood increased | |
| 125451052 | 12545105 | Normochromic normocytic anaemia | |
| 125451052 | 12545105 | Productive cough | |
| 125451052 | 12545105 | Pyrexia | |
| 125451052 | 12545105 | Troponin T increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125451052 | 12545105 | 1 | 20140929 | 0 | ||
| 125451052 | 12545105 | 2 | 20140929 | 0 | ||
| 125451052 | 12545105 | 3 | 20140929 | 0 |